REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Applied BioCode Corporation (Taiwan, China)

Main Activities: Research and Development in Nanotechnology
Full name: Applied BioCode Corporation Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Applied BioCode Corporation focused on R & D and manufacturing of a medical analysis and detection products. Company's diagnosis product includes detection of respiratory infections and oral transmitted diseases, gastrointestinal infections and other diseases. Applied BioCode was established in 2016, headquartered in Taipei.

Headquarters
6F., No.11, Ln. 28, Xingzhong Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Applied BioCode Corporation report to view the information.

Website: http://www.apbiocode.com/tw

Basic Information
Total Employees:
Purchase the Applied BioCode Corporation report to view the information.
Outstanding Shares:
Purchase the Applied BioCode Corporation report to view the information.
Financial Auditors:
Purchase the Applied BioCode Corporation report to view the information.
Incorporation Date:
April 15, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
10.16%
Purchase this report to view the information.
0.13%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Applied Biocode Inc. (United States)
100%
Company Performance
Financial values in the chart are available after Applied BioCode Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-3.32%▼
Total operating revenue
-3.32%▼
Operating profit (EBIT)
-19.13%▼
EBITDA
-26.77%▼
Net Profit (Loss) for the Period
-22.06%▼
Total assets
9.83%▲
Total equity
31.53%▲
Operating Profit Margin (ROS)
-14.9%▼
Net Profit Margin
-15.3%▼
Return on Equity (ROE)
1.6%▲
Debt to Equity Ratio
-3.24%▼
Quick Ratio
2.41%▲
Cash Ratio
3.68%▲

Similar companies

Foresee Pharmaceuticals Co., Ltd.
 
Terawins, Inc.
Pell Bio-Med Technology Co. Ltd.
 
Steminent Biotherapeutics Inc.

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo